F-group (family)

386.1.1.1 zf-C2H2

Ligands and drugs

7,857
Member domains
623
with ligand contacts (≤ 4 Å)
7.9% of members
341
with DrugDomain annotations
4.3% of members
25
with a DrugBank compound
0.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 386.1.1.1 belongs to X-group 386 beta-beta-alpha zinc fingers, which binds 3.9 ligand superclasses per 20 proteins, narrower than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02884—3-Cyclohexyl-L-alanine5
DB05483—Picolinic acid5
DB11326BO3Boric acid1
DB121018W7Iberdomide1
DB17584QFCMezigdomide1

Most frequently bound compounds

PDB ligandNameDomains in contact
ZNmetalZINC ION621
MGmetalMAGNESIUM ION10
Y70S-Pomalidomide9
RN93-[3-[[1-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-2,5-bis(oxidanylidene)pyrrol-3-yl]amino]phenyl]-~{N}-(3-chloranyl-4-methyl-phenyl)propanamide4
8W7(3S)-3-[4-({4-[(morpholin-4-yl)methyl]phenyl}methoxy)-1-oxo-1,3-dihydro-2H-isoindol-2-yl]piperidine-2,6-dione3
LWK(3S)-3-[5-(1-benzylpiperidin-4-yl)-1-oxo-1,3-dihydro-2H-isoindol-2-yl]piperidine-2,6-dione3
CAmetalCALCIUM ION2
CLCHLORIDE ION2
COmetalCOBALT (II) ION2
MIQ2-[(3S)-2,6-dioxopiperidin-3-yl]-5-(morpholin-4-yl)-1H-isoindole-1,3(2H)-dione2
NAmetalSODIUM ION2
QFCMezigdomide2
85C1-(3-chloro-4-methylphenyl)-3-({2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-2,3-dihydro-1H-isoindol-5-yl}methyl)urea1
A1CEKN-{2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-2,3-dihydro-1H-isoindol-5-yl}benzamide1
BO3BORIC ACID1
EF2S-Thalidomide1
F4U2-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-5-oxidanyl-isoindole-1,3-dione1
KmetalPOTASSIUM ION1